
Chemical and Pharmaceutical Bulletin p. 1130 - 1134 (1998)
Update date:2022-08-03
Topics:
Baba, Atsuo
Makino, Haruhiko
Ohta, Yoshikazu
Sohda, Takashi
The metabolites of ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2- (1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (1, TAK-603), which is under clinical evaluation as a new type of disease-modifying antirheumatic drug (DMARD), were prepared to confirm th
View MoreShandong Hongxiang Zinc Co., Ltd
Contact:086-0311-66187879
Address:DaWang developing zone
Contact:+86-158-05817090
Address:ROOM 9F, FLAT 2, GUODU DEVELOPING BLDG, No.182, ZHAOHUI ROAD
Zhushan County Tianxin Pharmaceutical & Chemical Co., Ltd.
Contact:0086-719-4224892
Address:Tutang Road, Chengguan Town, Zhushan County, Hubei Province
Cangzhou Senary Chemical Science-tech Co., Ltd
Contact:+86-317-3563899, 3563699
Address:168 Jinde Road, Cangzhou, Hebei, China
Contact:86-898-65311214
Address:Room 102, BLDG. 68 Jiangnan City, No. 66 Heping Road,Haikou, Hainan, China
Doi:10.1039/c6cc05707a
(2016)Doi:10.1039/a802797h
(1998)Doi:10.1039/a801922c
(1998)Doi:10.1021/jo01046a525
(1963)Doi:10.1016/j.jfluchem.2005.03.020
(2005)Doi:10.1055/s-2006-950244
(2006)